- Home
- BMEA vs AMTX Comparison
BMEA vs AMTX Comparison
Compare BMEA & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMEA
- AMTX
- Stock Information
- Founded
- BMEA 2017
- AMTX 2005
- Country
- BMEA United States
- AMTX United States
- Employees
- BMEA N/A
- AMTX N/A
- Industry
- BMEA Biotechnology: Pharmaceutical Preparations
- AMTX Major Chemicals
- Sector
- BMEA Health Care
- AMTX Industrials
- Exchange
- BMEA Nasdaq
- AMTX Nasdaq
- Market Cap
- BMEA 145.0M
- AMTX 128.6M
- IPO Year
- BMEA 2021
- AMTX N/A
- Fundamental
- Price
- BMEA $4.25
- AMTX $2.70
- Analyst Decision
- BMEA Buy
- AMTX Strong Buy
- Analyst Count
- BMEA 13
- AMTX 5
- Target Price
- BMEA $27.92
- AMTX $12.95
- AVG Volume (30 Days)
- BMEA 831.0K
- AMTX 625.2K
- Earning Date
- BMEA 10-29-2024
- AMTX 03-06-2025
- Dividend Yield
- BMEA N/A
- AMTX N/A
- EPS Growth
- BMEA N/A
- AMTX N/A
- EPS
- BMEA N/A
- AMTX N/A
- Revenue
- BMEA N/A
- AMTX $291,400,000.00
- Revenue This Year
- BMEA N/A
- AMTX $64.91
- Revenue Next Year
- BMEA N/A
- AMTX $42.21
- P/E Ratio
- BMEA N/A
- AMTX N/A
- Revenue Growth
- BMEA N/A
- AMTX 59.51
- 52 Week Low
- BMEA $3.61
- AMTX $2.10
- 52 Week High
- BMEA $20.21
- AMTX $7.03
- Technical
- Relative Strength Index (RSI)
- BMEA 42.32
- AMTX 42.94
- Support Level
- BMEA $3.78
- AMTX $2.56
- Resistance Level
- BMEA $4.29
- AMTX $2.92
- Average True Range (ATR)
- BMEA 0.30
- AMTX 0.20
- MACD
- BMEA 0.15
- AMTX 0.02
- Stochastic Oscillator
- BMEA 89.71
- AMTX 25.93
About BMEA Biomea Fusion Inc.
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.
About AMTX Aemetis Inc. (DE)
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into advanced biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.